{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:50:14Z","timestamp":1777431014729,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1245\/aso.2004.07.013","type":"journal-article","created":{"date-parts":[[2004,5,25]],"date-time":"2004-05-25T00:23:17Z","timestamp":1085444597000},"page":"612-618","source":"Crossref","is-referenced-by-count":34,"title":["Prognostic Factors in Resected Pathologic (p-) Stage IIIA-N2, Non-Small-Cell Lung Cancer"],"prefix":"10.1245","volume":"11","author":[{"given":"Fumihiro","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Otake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yozo","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Katakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1378\/chest.111.6.1710","volume":"116","author":"CF Mountain","year":"1997","unstructured":"Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;116:1710?7.","journal-title":"Chest"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1010-7940(00)00490-5","volume":"18","author":"F Tanaka","year":"2000","unstructured":"Tanaka F, Yanagihara K, Otake Y, et al. Surgery for non-small cell lung cancer: postoperative survival based on the revised tumor-node-metastasis classification and its time trend. Eur J Cardiothorac Surg 2000;18:147?55.","journal-title":"Eur J Cardiothorac Surg"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0003-4975(97)00314-7","volume":"63","author":"JF Vansteenkiste","year":"1997","unstructured":"Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Ann Thorac Surg 1997;63:1441?50.","journal-title":"Ann Thorac Surg"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0022-5223(99)70217-5","volume":"118","author":"M Okada","year":"1999","unstructured":"Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Matsuoka H. Prognosis of completely resected pN2 non-small cell lung carcinomas: what is the significant node that affects survival?. J Thorac Cardiovasc Surg 1999;118:270?5.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0169-5002(01)00207-0","volume":"34","author":"Y Ichinose","year":"2001","unstructured":"Ichinose Y, Kato H, Koike T, et al. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer 2001;34:29?36.","journal-title":"Lung Cancer"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1200\/JCO.1997.15.8.2858","volume":"15","author":"U Pastorino","year":"1997","unstructured":"Pastorino U, Andreola S, Tagliabue E, et al. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol 1997;15:2858?65.","journal-title":"J Clin Oncol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<409::AID-CNCR5>3.0.CO;2-E","volume":"78","author":"CA Angeletti","year":"1996","unstructured":"Angeletti CA, Lucchi M, Fontanini G, et al. Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Cancer 1996;78:409?15.","journal-title":"Cancer"},{"key":"CR8","first-page":"4055","volume":"6","author":"T Mitsudomi","year":"2000","unstructured":"Mitsudomi T, Hamajima N, Ogawa M, Takahashi T. Prognostic significance of p53 alternations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res 2000;6:4055?63.","journal-title":"Clin Cancer Res"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1054\/bjoc.2000.1579","volume":"84","author":"F Tanaka","year":"2001","unstructured":"Tanaka F, Otake Y, Yanagihara K, et al. Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer. Br J Cancer 2001;84:263?9.","journal-title":"Br J Cancer"},{"key":"CR10","first-page":"3410","volume":"7","author":"F Tanaka","year":"2001","unstructured":"Tanaka F, Otake Y, Yanagihara K, et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res 2001;7:3410?5.","journal-title":"Clin Cancer Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.1997.15.8.2996","volume":"15","author":"American Society of Clinical Oncology.","year":"1997","unstructured":"American Society of Clinical Oncology. ASCO special article: Clinical practical guidelines for the treatment of unresectable non-small cell lung cancer. J Clin Oncol 1997;15:2996?3018.","journal-title":"J Clin Oncol"},{"key":"CR12","first-page":"856","volume":"59","author":"S Kumar","year":"1999","unstructured":"Kumar S, Ghellal A, Li C, et al. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 1999;59:856?61.","journal-title":"Cancer Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/S0003-4975(00)01987-1","volume":"70","author":"F Tanaka","year":"2000","unstructured":"Tanaka F, Yanagihara K, Otake Y, et al. Biological features and preoperative evaluation of mediastinal nodal status in non-small cell lung cancer. Ann Thorac Surg 2000;70:1832?8.","journal-title":"Ann Thorac Surg"},{"key":"CR14","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-60049-4","volume-title":"World Health Organization International Histological Classification of Tumors: Histological Typing of Lung and Pleural Tumors","author":"WD Travis","year":"1999.","unstructured":"Travis WD, Colby TV, Shimosato, Corrin, Y, Brambilla E. World Health Organization International Histological Classification of Tumors: Histological Typing of Lung and Pleural Tumors. 3rd ed. Berlin: Springer, 1999.","edition":"3rd ed."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1200\/JCO.1996.14.4.1048","volume":"14","author":"H Wada","year":"1996","unstructured":"Wada H, Hitomi S, Teramatsu T. West Japan Study Group for Lung Cancer Surgery. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. J Clin Oncol 1996;14:1048?54.","journal-title":"J Clin Oncol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1010-7940(99)00031-7","volume":"15","author":"H Wada","year":"1999","unstructured":"Wada H, Miyahara R, Tanaka F, Hitomi S. Postoperative adjuvant chemotherapy with PVM (cisplatin + vindesine + mitomycin C) and UFT (uracil + tegaful) in resected stage I-II NSCLC (non-small-cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG). Eur J Cardiothorac Surg 1999;15:438?43.","journal-title":"Eur J Cardiothorac Surg"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.1999.17.9.2728","volume":"17","author":"F Tanaka","year":"1999","unstructured":"Tanaka F, Kawano Y, Li M, et al. Prognostic significance of apoptotic index in completely resected non-small cell lung cancer. J Clin Oncol 1999;17:2728?36.","journal-title":"J Clin Oncol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/339058a0","volume":"339","author":"J Folkman","year":"1989","unstructured":"Folkman J, Watson K, Ingiber D, Hanahan D. Induction of angiogenesis during transition from hyperplasia to neoplasia. Nature (Lond) 1989;339:58?61.","journal-title":"Nature (Lond)"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0003-4975(96)00104-X","volume":"61","author":"DH Harpole Jr","year":"1996","unstructured":"Harpole, Jr DH, Richards WG, Herndon II JE, Sugarbaker DJ. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann Thorac Surg 1996;61:1470?6.","journal-title":"Ann Thorac Surg"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1010-7940(97)00218-2","volume":"12","author":"M Lucchi","year":"1997","unstructured":"Lucchi M, Fontanini G, Mussi A, et al. Tumor angiogenesis and biologic markers in resected stage I NSCLC. Eur J Cardiothorac Surg 1997;12:535?41.","journal-title":"Eur J Cardiothorac Surg"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0022-5223(98)70331-9","volume":"115","author":"IG Duarte","year":"1998","unstructured":"Duarte IG, Bufkin BL, Pennington MF, et al. Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 1998;115:652?9.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.1997.15.6.2456","volume":"15","author":"RM Apolinario","year":"1997","unstructured":"Apolinario RM, van der Valk P, de Jong JS, et al. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small cell lung cancer. J Clin Oncol 1997;15:2456?66.","journal-title":"J Clin Oncol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1010-7940(01)00670-4","volume":"19","author":"F Tanaka","year":"2001","unstructured":"Tanaka F, Yanagohara K, Otake Y, et al. Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC). Eur J Cardiothorac Surg 2001;19:555?61.","journal-title":"Eur J Cardiothorac Surg"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1200\/JCO.2000.18.16.2981","volume":"18","author":"F Andre","year":"2000","unstructured":"Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000;18:2981?9.","journal-title":"J Clin Oncol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1200\/JCO.2001.19.1.111","volume":"19","author":"V Kalff","year":"2000","unstructured":"Kalff V, Hicks RJ, MacManus MP, et al. Clinical impact of 18F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J Clin Oncol 2000;19:111?8.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/ASO.2004.07.013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/ASO.2004.07.013\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/ASO.2004.07.013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:18:30Z","timestamp":1572970710000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/ASO.2004.07.013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["612"],"URL":"https:\/\/doi.org\/10.1245\/aso.2004.07.013","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}